major adverse cardiac events

https://www.aafp.org/afp/2017/1001/od1 Prolonged Dual Antiplatelet Therapy After MI Reduces Major Adverse Cardiac Events | AFP In patients who are stable one year post-MI, prolonged use of dual antiplatelet therapy may be an effective treatment to decrease major cardiac events and... major adverse cardiac events dual antiplatelet therapy https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2014/09/25/21/24/Long-Term-Clinical-Outcome-of-Major-Adverse-Cardiac-Events Long-Term Clinical Outcome of Major Adverse Cardiac Events in Survivors of Infectious Endocarditis:... major adverse cardiac events https://www.fda.gov/medical-devices/letters-health-care-providers/fda-investigating-increased-rate-major-adverse-cardiac-events-observed-patients-receiving-abbott FDA Investigating Increased Rate of Major Adverse Cardiac Events Observed in Patients Receiving... Alert for health professionals treating patients with Absorb GT1 Bioresorbable Vascular Scaffold (BVS) that there is an increased rate of major adverse cardiac... major adverse cardiac events https://www.biospace.com/ffr-search-shows-clear-trend-towards-major-adverse-cardiac-events-with-lower-ffr FFR-SEARCH Shows Clear Trend Towards Major Adverse Cardiac Events with Lower FFR - BioSpace Jun 20, 2019 - Dr. Roberto Diletti from The Erasmus Center in Rotterdam, Netherlands, presented the results of the two-year follow-up analysis of the FFR-SEARCH observational... major adverse cardiac events

Robuta